AnaptysBio
Price & Volume
Stats
See more52W Range | $12.21-$41.30 |
Market Cap | $574.1M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $57.1M |
Revenue Growth (YoY) | 804.7% |
Gross Profit (12 Mos) | -$97.6M |
Diluted EPS | -$6.05 |
News
See moreYahoo Finance • 10 days ago
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
Yahoo Finance • 11 days ago
Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025
Yahoo Finance • 19 days ago
Anaptys to Present at the Guggenheim SMID Cap Biotech Conference
About
CEO | Mr. Daniel R. Faga |
Address | 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 117 |
